| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 330,455 | 334,013 | 377,960 | 405,211 | | Cost of Revenue | 235,629 | 242,380 | 271,475 | 299,415 | | | Gross Profit | 94,826 | 91,633 | 106,485 | 105,796 | | | Operating Expenses | | Research Development | 10,157 | 10,765 | 10,559 | 9,656 | | Selling General and Administrative | 37,395 | 42,346 | 38,787 | 44,275 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,515 | 1,795 | 1,391 | 1,611 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,759 | 36,727 | 55,748 | 50,254 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 394 | (134) | 389 | 1,471 | | Earnings Before Interest And Taxes | 46,153 | 36,593 | 56,137 | 51,725 | | Interest Expense | 3,687 | 3,525 | 4,936 | 3,791 | | Income Before Tax | 42,466 | 33,068 | 51,201 | 47,934 | | Income Tax Expense | 15,118 | 2,232 | 18,535 | 16,825 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 27,348 | 30,836 | 32,666 | 31,109 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,348 | 30,836 | 32,666 | 31,109 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,348 | $30,836 | $32,666 | $31,109 |
|
0.29% Nasdaq 
Income Statement
